Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125361021 | 12536102 | 1 | I | 20150303 | 20160707 | 20160707 | EXP | JP-ELI_LILLY_AND_COMPANY-JP201503001171 | ELI LILLY AND CO | 33.00 | YR | F | Y | 54.00000 | KG | 20160707 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125361021 | 12536102 | 1 | PS | HUMULIN R | INSULIN HUMAN | 1 | Intravenous (not otherwise specified) | UNK, DAY 1 OF HOSPITALIZATION | Y | 18780 | INJECTION | ||||||||
| 125361021 | 12536102 | 2 | SS | HUMULIN R | INSULIN HUMAN | 1 | Unknown | 6-2-10-0, DAY 2 OF HOSPITALIZATION | Y | 0 | |||||||||
| 125361021 | 12536102 | 3 | SS | HUMULIN R | INSULIN HUMAN | 1 | Unknown | 6-6-4-0, DAY 3 OF HOSPITALIZATION | Y | 0 | |||||||||
| 125361021 | 12536102 | 4 | SS | HUMULIN N | INSULIN HUMAN | 1 | Unknown | 20 IU, QD, DAY 2 OF HOSPITALIZATION | Y | 0 | 20 | IU | QD | ||||||
| 125361021 | 12536102 | 5 | SS | HUMULIN N | INSULIN HUMAN | 1 | Unknown | 20 IU, QD, DAY 3 OF HOSPITALIZATION | Y | 0 | 30 | IU | QD | ||||||
| 125361021 | 12536102 | 6 | SS | HUMALOG | INSULIN LISPRO | 1 | Subcutaneous | UNK | 0 | INJECTION | |||||||||
| 125361021 | 12536102 | 7 | C | INSULIN DETEMIR | INSULIN DETEMIR | 1 | Subcutaneous | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125361021 | 12536102 | 1 | Fulminant type 1 diabetes mellitus |
| 125361021 | 12536102 | 2 | Fulminant type 1 diabetes mellitus |
| 125361021 | 12536102 | 4 | Fulminant type 1 diabetes mellitus |
| 125361021 | 12536102 | 6 | Fulminant type 1 diabetes mellitus |
| 125361021 | 12536102 | 7 | Fulminant type 1 diabetes mellitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125361021 | 12536102 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125361021 | 12536102 | Blood glucose fluctuation | |
| 125361021 | 12536102 | Blood glucose increased | |
| 125361021 | 12536102 | Maternal exposure during pregnancy | |
| 125361021 | 12536102 | Threatened labour |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |